Daily Rimegepant for Migraine Prevention
Recruiting in Palo Alto (17 mi)
+29 other locations
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: Biohaven Pharmaceutical Holding Company Ltd.
No Placebo Group
Prior Safety Data
Approved in 6 jurisdictions
Trial Summary
What is the purpose of this trial?The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.
Eligibility Criteria
This trial is for adults over 18 with a history of episodic migraines, experiencing 4-14 attacks per month. Participants should have had migraines for at least one year and typically last between 4 to 72 hours if untreated. It's not suitable for those who started having migraines before age 50 or use opioids/barbiturates frequently.Inclusion Criteria
I have had migraines for at least 1 year.
My migraines last between 4 to 72 hours without treatment.
I am 18 years old or older.
Participant Groups
The study tests the long-term safety and tolerability of daily doses of Rimegepant, a medication aimed at preventing episodic migraines. The focus is on understanding how well individuals can handle taking this drug every day over an extended period.
1Treatment groups
Experimental Treatment
Group I: RimegepantExperimental Treatment1 Intervention
rimegepant 75 mg ODT daily
Rimegepant is already approved in United States, European Union, Canada, United Kingdom for the following indications:
🇺🇸 Approved in United States as Nurtec ODT for:
- Acute treatment of migraine with or without aura in adults
- Preventative treatment of episodic migraine in adults
🇪🇺 Approved in European Union as Vydura for:
- Prophylaxis and acute treatment of migraine in adults
🇨🇦 Approved in Canada as Nurtec ODT for:
- Acute treatment of migraine with or without aura in adults
- Preventative treatment of episodic migraine in adults
🇬🇧 Approved in United Kingdom as Vydura for:
- Prophylaxis and acute treatment of migraine in adults
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Aventiv ResearchDublin, OH
VIP TrailsSan Antonio, TX
Tidewater Integrated Medical ResearchVirginia Beach, VA
Aventiv Research, Inc. d/b/a/ Centricity ResearchDublin, OH
More Trial Locations
Loading ...
Who is running the clinical trial?
Biohaven Pharmaceutical Holding Company Ltd.Lead Sponsor
PfizerLead Sponsor